Troughton Mark T. - 12 Jun 2025 Form 4 Insider Report for Chime Financial, Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Jun 2025, 19:47:51 UTC
Prior SEC filing
11 Jun 2025
Next SEC filing
10 Sep 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Theresa Bloom, by power of attorney

Key filing fact

Troughton Mark T. filed Form 4 for Chime Financial, Inc. on 13 Jun 2025.

Key facts

  • This page summarizes Troughton Mark T.'s Form 4 filing for Chime Financial, Inc..
  • 13 reported transactions and 10 derivative rows are listed below.
  • Accepted by SEC: 13 Jun 2025, 19:47.

Change

  • Previous filing in this sequence was filed on 11 Jun 2025.
  • Current net transaction value: -$2,799,306.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001494393 Primary reporting owner

Troughton Mark T

Relationship
CHIEF OPERATING OFFICER
Address
C/O CHIME FINANCIAL, INC., 101 CALIFORNIA STREET, SUITE 500, SAN FRANCISCO
Signature
/s/ Theresa Bloom, by power of attorney
Signature date
13 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CHYM transaction

Common Stock

Tax liability

Transaction value
$2,799,306
Shares
-103,678
Change %
-3.8%
Price
$27.00
Shares after
2,653,622
Date
12 Jun 2025
Ownership
Direct
Footnotes
F1, F2, F3
CHYM transaction

Common Stock

Other

Transaction value
Shares
-2,653,622
Change %
-100%
Price
Shares after
0
Date
13 Jun 2025
Ownership
Direct
Footnotes
F2
CHYM transaction

Class A Common Stock

Other

Transaction value
Shares
+2,653,622
Change %
Price
Shares after
2,653,622
Date
13 Jun 2025
Ownership
Direct
Footnotes
F2, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CHYM transaction Derivative

Employee Stock Option (Right to buy)

Other

Transaction value
Shares
-500,000
Change %
-100%
Price
Shares after
0
Date
13 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
500,000
Exercise price
$6.19
Footnotes
F2, F5
CHYM transaction Derivative

Employee Stock Option (Right to buy)

Other

Transaction value
Shares
+500,000
Change %
Price
Shares after
500,000
Date
13 Jun 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
500,000
Exercise price
$6.19
Footnotes
F2, F5
CHYM transaction Derivative

Employee Stock Option (Right to buy)

Other

Transaction value
Shares
-233,333
Change %
-100%
Price
Shares after
0
Date
13 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
233,333
Exercise price
$13.89
Footnotes
F2, F6
CHYM transaction Derivative

Employee Stock Option (Right to buy)

Other

Transaction value
Shares
+233,333
Change %
Price
Shares after
233,333
Date
13 Jun 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
233,333
Exercise price
$13.89
Footnotes
F2, F6
CHYM transaction Derivative

Employee Stock Option (Right to buy)

Other

Transaction value
Shares
-600,000
Change %
-100%
Price
Shares after
0
Date
13 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
600,000
Exercise price
$15.70
Footnotes
F2, F7
CHYM transaction Derivative

Employee Stock Option (Right to buy)

Other

Transaction value
Shares
+600,000
Change %
Price
Shares after
600,000
Date
13 Jun 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
600,000
Exercise price
$15.70
Footnotes
F2, F7
CHYM transaction Derivative

Employee Stock Option (Right to buy)

Other

Transaction value
Shares
-233,400
Change %
-100%
Price
Shares after
0
Date
13 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
233,400
Exercise price
$27.90
Footnotes
F2, F8
CHYM transaction Derivative

Employee Stock Option (Right to buy)

Other

Transaction value
Shares
+233,400
Change %
Price
Shares after
233,400
Date
13 Jun 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
233,400
Exercise price
$27.90
Footnotes
F2, F8
CHYM transaction Derivative

Employee Stock Option (Right to buy)

Other

Transaction value
Shares
-383,400
Change %
-100%
Price
Shares after
0
Date
13 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
383,400
Exercise price
$27.90
Footnotes
F2, F9
CHYM transaction Derivative

Employee Stock Option (Right to buy)

Other

Transaction value
Shares
+383,400
Change %
Price
Shares after
383,400
Date
13 Jun 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
383,400
Exercise price
$27.90
Footnotes
F2, F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

These shares have been withheld by the Issuer, in an exempt disposition to the Issuer under Rule 16b-3(e), to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units ("RSUs") pursuant to the Issuer's initial public offering of Class A Common Stock (the "IPO").

Footnote F2

Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the IPO.

Footnote F3

Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

Footnote F4

Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

Footnote F5

All of the shares subject to the option are fully vested and exercisable as of the date hereof.

Footnote F6

1/48th of the shares subject to the option vested on March 7, 2023 and 1/48th of the shares vest monthly thereafter, subject to the Reporting Person's continued service through each vesting date.

Footnote F7

1/48th of the shares subject to the option vested on October 1, 2023 and 1/48th of the shares vest monthly thereafter, subject to the Reporting Person's continued service through each vesting date.

Footnote F8

1/48th of the shares subject to the option vested on March 15, 2025 and 1/48th of the shares vest monthly thereafter, subject to the Reporting Person's continued service through each vesting date.

Footnote F9

10% of shares subject to the option vest on each of February 15, 2026 and February 15, 2027, 30% of shares subject to the option vest on February 15, 2028, and 50% of shares subject to the option vest on February 15, 2029, subject to the Reporting Person's continued service through each vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .